842252692	842252692	CD	B-NP	O
|	|	NN	I-NP	O
FH	FH	NN	I-NP	O
|	|	NN	I-NP	O
72771864	72771864	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
791656	791656	CD	B-NP	O
|	|	CC	I-NP	O
5/21/1998	5/21/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/11/1998	6/11/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/20/1998	6/20/1998	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

SEVERE	SEVERE	NNP	B-NP	O
PANCREATIC	PANCREATIC	NNP	I-NP	O
EXOCRINE	EXOCRINE	NNP	I-NP	O
AND	AND	CC	O	O
ENDOCRINE	ENDOCRINE	NNP	B-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

SEVERE	SEVERE	NN	B-NP	O
ACUTE	ACUTE	NN	I-NP	O
PANCREATITIS	PANCREATITIS	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

NEW	NEW	NNP	B-NP	O
ONSET	ONSET	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERGLYCEMIC	HYPERGLYCEMIC	NN	B-NP	O
,	,	,	O	O
HYPEROSMOLAR	HYPEROSMOLAR	NN	B-NP	O
,	,	,	O	O
NONKETOTIC	NONKETOTIC	NN	B-NP	B-protein
ACIDOSIS	ACIDOSIS	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
NOW	NOW	RB	B-ADVP	O
RESOLVED	RESOLVED	VBD	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ACUTE	ACUTE	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
NOW	NOW	RB	B-NP	O
RESOLVED	RESOLVED	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

RHABDOMYOLYSIS	RHABDOMYOLYSIS	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
NOW	NOW	RB	B-NP	O
RESOLVED	RESOLVED	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

SEVERE	SEVERE	NN	B-NP	O
ALCOHOLISM	ALCOHOLISM	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

CONGENITAL	CONGENITAL	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
BLOCK	BLOCK	NNP	I-NP	O
,	,	,	O	O
STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
PACEMAKER	PACEMAKER	NNP	I-NP	O
PLACEMENT	PLACEMENT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
1980	1980	CD	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
SILENT	SILENT	NNP	I-NP	O
IMI	IMI	NNP	I-NP	O
IN	IN	NNP	I-NP	O
1988	1988	CD	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
DILATED	DILATED	NNP	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	O
,	,	,	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
LAST	LAST	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
PERFORMED	PERFORMED	NNP	I-NP	O
ON	ON	NNP	I-NP	O
20	20	CD	I-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
WITH	WITH	NNP	I-NP	O
AN	AN	NNP	I-NP	O
ESTIMATED	ESTIMATED	NNP	I-NP	O
EJECTION	EJECTION	NNP	I-NP	O
FRACTION	FRACTION	NNP	I-NP	O
OF	OF	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
LEFT	LEFT	NNP	I-NP	O
NEPHRECTOMY	NEPHRECTOMY	NNP	I-NP	O
SECONDARY	SECONDARY	NNP	I-NP	O
TO	TO	NNP	I-NP	O
NEPHROLITHIASIS	NEPHROLITHIASIS	NNP	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
GERD	GERD	NNP	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
SPINAL	SPINAL	NNP	B-NP	O
STENOSIS	STENOSIS	NNP	I-NP	O
,	,	,	O	O
LOWER	LOWER	NNP	B-NP	O
EXTREMITY	EXTREMITY	NNP	I-NP	O
PAIN	PAIN	NNP	I-NP	O
AND	AND	NNP	I-NP	O
SCIATICA	SCIATICA	NNP	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

PERIPHERAL	PERIPHERAL	NNP	B-NP	O
VASCULAR	VASCULAR	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
CLAUDICATION	CLAUDICATION	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
APPENDECTOMY	APPENDECTOMY	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
RECURRENT	RECURRENT	NN	B-NP	O
URINARY	URINARY	NN	I-NP	O
TRACT	TRACT	NN	I-NP	O
INFECTIONS	INFECTIONS	NNS	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
MEDICAL	MEDICAL	JJ	B-NP	O
NONADHERENCE	NONADHERENCE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60	60	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
African	African	JJ	I-NP	O
-	-	HYPH	I-NP	O
American	American	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complicated	complicated	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
severe	severe	JJ	B-NP	O
alcoholism	alcoholism	NN	I-NP	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
had	have	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
also	also	RB	B-ADVP	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
nonadherence	nonadherence	NN	I-NP	O
,	,	,	O	O
noncompliance	noncompliance	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Dubrey	Dubrey	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
myalgias	myalgia	NNS	B-NP	O
,	,	,	O	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
lb	lb	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
167	167	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
158	158	CD	B-NP	I-DNA
in	in	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
his	his	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure/cardiac	failure/cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
probably	probably	RB	I-NP	O
URI	URI	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
refilled	refill	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
PPD	PPD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
getting	get	VBG	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
progressive	progressive	JJ	B-NP	O
malaise	malaise	NN	I-NP	O
,	,	,	O	O
anorexia	anorexia	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
increased	increase	VBN	I-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
girlfriend	girlfriend	NN	I-NP	O
but	but	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
complaints	complaint	NNS	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
lethargic	lethargic	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
mumbling	mumble	VBG	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
girlfriend	girlfriend	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
EMTs	EMT	NNS	I-NP	O
were	be	VBD	B-VP	O
called	call	VBN	I-VP	O
who	who	WP	B-NP	O
found	find	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
somewhat	somewhat	RB	B-ADJP	O
somnolent	somnolent	JJ	I-ADJP	O
but	but	CC	I-ADJP	O
arousable	arousable	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
483	483	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110	110	CD	I-NP	O
/	/	SYM	I-NP	O
palp	palp	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Tabell	Tabell	NNP	I-NP	O
Aleretsentla	Aleretsentla	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
two	two	CD	B-NP	O
with	with	IN	B-PP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
89	89	CD	B-NP	O
rectally	rectally	RB	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/68	120/68	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
28	28	CD	I-NP	O
,	,	,	I-NP	O
O2	O2	CD	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gases	gas	NNS	I-NP	O
pH	pH	NN	I-NP	O
was	be	VBD	B-VP	O
7.13	7.13	CD	B-NP	O
,	,	,	O	O
pO2	pO2	NN	B-NP	O
326	326	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
28	28	CD	I-NP	O
.	.	.	O	O

Acetest	Acetest	NN	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

Betahydroxy	Betahydroxy	NN	B-NP	O
butyrate	butyrate	NN	I-NP	O
of	of	IN	B-PP	O
1.66	1.66	CD	B-NP	O
.	.	.	O	O

serum	serum	NN	B-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
at	at	IN	B-PP	O
1800	1800	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
anion	anion	NN	I-NP	O
gap	gap	NN	I-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
serum	serum	NN	B-NP	B-protein
sodium	sodium	NN	I-NP	I-protein
129	129	CD	I-NP	I-protein
,	,	,	O	O
serum	serum	NN	B-NP	B-protein
potassium	potassium	NN	I-NP	I-protein
7.6	7.6	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
178	178	CD	I-NP	I-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
7.5	7.5	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
IV	IV	CD	I-NP	O
over	over	IN	I-NP	O
five	five	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
two	two	CD	B-NP	O
amps	amp	NNS	I-NP	O
of	of	IN	B-PP	O
bicarb	bicarb	NN	B-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
grams	gram	NNS	I-NP	O
of	of	IN	B-PP	O
Kayexalate	Kayexalate	NNP	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
amp	amp	NN	I-NP	O
of	of	IN	B-PP	O
calcium	calcium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
,	,	,	O	O
Solu-Cortef	Solu-Cortef	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
ceftriaxone	ceftriaxone	NN	B-NP	O
two	two	CD	B-NP	O
grams	gram	NNS	I-NP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
markedly	markedly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
see	see	VB	B-VP	O
problem	problem	NN	B-NP	O
list	list	NN	I-NP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
alcoholism	alcoholism	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
preadmission	preadmission	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
binges	binge	VBZ	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
;	;	:	O	O
but	but	CC	O	O
,	,	,	O	O
later	later	RB	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
drinking	drinking	NN	B-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
gallons	gallon	NNS	I-NP	O
of	of	IN	B-PP	O
gin	gin	NN	B-NP	B-protein
and	and	CC	I-NP	O
vodka	vodka	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
friends	friend	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
drinking	drink	VBG	B-VP	O
many	many	JJ	B-NP	O
beers	beer	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
echo	echo	NN	I-NP	O
previously	previously	RB	B-ADVP	O
the	the	DT	B-NP	O
one	one	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
11/27	11/27	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
anteroseptal	anteroseptal	JJ	B-NP	B-protein
HK	HK	NN	I-NP	I-protein
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
HK	HK	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
AK	AK	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
AR	AR	NN	I-NP	B-protein
and	and	CC	O	O
an	an	DT	B-NP	O
ETT	ETT	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
in	in	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
showed	show	VBD	B-VP	O
IMI	IMI	NNP	B-NP	O
,	,	,	O	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
repeated	repeat	VBN	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
approximate	approximate	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
and	and	CC	I-NP	O
septal	septal	JJ	I-NP	O
HK	HK	NN	I-NP	O
only	only	RB	B-ADVP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
-	-	HYPH	B-NP	O
enteric	enteric	JJ	I-NP	O
coated	coat	VBN	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
SL	SL	NN	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Naprosyn	Naprosyn	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
alcoholism	alcoholism	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
drinking	drink	VBG	I-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
month	month	NN	I-NP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
pack	pack	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
smoking	smoking	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
times	time	NNS	I-NP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
girlfriend	girlfriend	NN	I-NP	O
and	and	CC	O	O
``	``	``	B-NP	O
step-daughter	step-daughter	NN	I-NP	O
''	''	''	O	O
in	in	IN	B-PP	O
Montesonnixcape	Montesonnixcape	NNP	B-NP	O
Broke	Broke	NNP	I-NP	O
Sonpo	Sonpo	NNP	I-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
and	and	CC	I-NP	O
mother	mother	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
mother	mother	NN	I-NP	O
also	also	RB	B-ADVP	O
``	``	``	O	O
cancer	cancer	NN	B-NP	O
''	''	''	O	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
-	-	HYPH	O	O
Temperature	Temperature	NN	B-NP	B-protein
94.0	94.0	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
100/66	100/66	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
facemask	facemask	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
28	28	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
voice	voice	NN	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
En	En	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
said	say	VBD	B-VP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
ears	ear	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
,	,	,	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
-	-	HYPH	O	O
Had	Have	VBD	B-VP	O
few	few	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
-	-	HYPH	I-NP	O
Regular	Regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	I-NP	O
regurg	regurg	NN	I-NP	O
or	or	CC	I-NP	O
gallop	gallop	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	B-NP	O
diffusely	diffusely	RB	I-NP	O
tender	tender	NN	I-NP	O
,	,	,	O	O
mildly	mildly	RB	B-VP	O
distended	distend	VBN	I-VP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
palpated	palpate	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
heme	heme	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
-	-	HYPH	B-NP	O
Trace	Trace	NN	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
cool	cool	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
skin	skin	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
petechiae	petechiae	FW	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rash	rash	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
splinters	splinter	NNS	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-ADJP	O
-	-	HYPH	O	O
He	He	PRP	B-NP	B-DNA
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	B-protein
right	right	JJ	I-NP	I-protein
ankle	ankle	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
0	0	CD	B-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
left	left	JJ	I-NP	O
toe	toe	NN	I-NP	O
was	be	VBD	B-VP	O
downgoing	downgoe	VBG	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
toe	toe	NN	I-NP	O
was	be	VBD	B-VP	O
equivocal	equivocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
WBC	WBC	NN	I-NP	B-protein
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
43	43	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
160	160	CD	B-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bandemia	bandemia	NN	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
,	,	,	O	O
81	81	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.3	1.3	CD	I-NP	I-protein
,	,	,	O	O
SMA-7	SMA-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
129	129	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
7.6	7.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
91	91	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
178	178	CD	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
7.5	7.5	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
1800	1800	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
126	126	CD	B-NP	O
,	,	,	O	O
troponion-I	troponion-I	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
0	0	CD	B-NP	I-protein
.	.	.	O	O

Lipase	Lipase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
22	22	CD	B-NP	O
,	,	,	I-NP	O
610	610	CD	I-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
2840	2840	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
174	174	CD	I-NP	I-protein
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
T-bili	T-bili	NNP	B-NP	O
of	of	IN	B-PP	O
0.4	0.4	CD	B-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
of	of	IN	B-PP	O
3.5	3.5	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.3	9.3	CD	I-NP	O
.	.	.	O	O

Phos	Phos	NN	B-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
12.8	12.8	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
5.2	5.2	CD	B-NP	O
.	.	.	O	O

UA	UA	NNP	B-NP	O
was	be	VBD	B-VP	O
19.5	19.5	CD	B-NP	O
.	.	.	O	O

ACETEST	ACETEST	NN	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
betahydroxybutyrate	betahydroxybutyrate	NN	I-NP	O
was	be	VBD	B-VP	O
1.66	1.66	CD	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
0.8	0.8	CD	B-NP	O
,	,	,	O	O
tox	tox	NN	B-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
-	-	HYPH	O	O
had	have	VBD	B-VP	O
0-1	0-1	NN	B-NP	O
wbcs	wbc	NNS	I-NP	O
,	,	,	O	O
SG	SG	NN	B-NP	O
of	of	IN	B-PP	O
1.023	1.023	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
pacing	pacing	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
77	77	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
or	or	CC	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
by	by	IN	B-PP	O
labs	lab	NNS	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
severe	severe	JJ	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
either	either	CC	O	O
a	a	DT	B-NP	O
DKA	DKA	NN	I-NP	B-protein
or	or	CC	I-NP	O
HHNKA	HHNKA	NN	I-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
not	not	RB	O	O
in	in	IN	B-PP	O
DKA	DKA	NN	B-NP	B-protein
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
betahydroxybutyrate	betahydroxybutyrate	NN	B-NP	O
of	of	IN	B-PP	O
1.66	1.66	CD	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
enought	enought	VBN	I-VP	O
to	to	TO	I-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
gap	gap	NN	I-NP	O
or	or	CC	O	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
metabolic	metabolic	JJ	I-NP	O
disturbances	disturbance	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
service	service	NN	I-NP	O
that	that	IN	B-NP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
hyperglycemic	hyperglycemic	JJ	B-NP	O
,	,	,	I-NP	O
hyperosmolar	hyperosmolar	JJ	I-NP	O
,	,	,	I-NP	O
nonketotic	nonketotic	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
severe	severe	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
screens	screen	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
including	include	VBG	I-NP	O
stones	stone	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
drinking	drink	VBG	I-VP	O
alcohol	alcohol	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
pancreatic	pancreatic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
metabolic	metabolic	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
correct	correct	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
by	by	IN	B-PP	O
labs	lab	NNS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
nonoliguric	nonoliguric	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
dehydration	dehydration	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hyperosmolar	hyperosmolar	JJ	B-NP	O
state	state	NN	I-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
were	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
ATN	ATN	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
gallstones	gallstone	NNS	B-NP	O
or	or	CC	O	O
biliary	biliary	JJ	B-NP	O
duct	duct	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
showed	show	VBD	B-VP	O
grade	grade	NN	B-NP	O
I	I	CD	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pseudocyst	pseudocyst	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
clinical	clinical	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
rhabdomyolysis	rhabdomyolysis	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
hypophosphatemic	hypophosphatemic	JJ	I-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
completely	completely	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CKs	CK	NNS	I-NP	B-protein
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
phosphate	phosphate	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CKs	CK	NNS	I-NP	B-protein
peaked	peak	VBD	B-VP	O
around	around	IN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
began	begin	VBD	I-VP	O
to	to	TO	I-VP	O
fall	fall	VB	I-VP	O
steadily	steadily	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
hydration	hydration	NN	I-NP	O
improved	improve	VBD	B-VP	O
steadily	steadily	RB	B-ADVP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
signs	sign	NNS	I-NP	O
which	which	WDT	B-NP	O
prompted	prompt	VBD	B-VP	O
an	an	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
exploratory	exploratory	JJ	I-NP	O
laparotomy	laparotomy	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
abdominal	abdominal	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
only	only	RB	B-NP	O
severe	severe	JJ	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
25	25	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
postoperatively	postoperatively	RB	B-ADVP	O
back	back	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
wean	wean	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
of	of	IN	B-PP	O
dextrose	dextrose	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
normalized	normalize	VBD	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
normalized	normalize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
by	by	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
had	have	VBD	B-VP	O
marked	mark	VBN	I-VP	O
decreased	decrease	VBN	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
normalized	normalize	VBD	B-VP	O
electrolytes	electrolyte	NNS	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
to	to	TO	B-PP	O
our	our	PRP$	B-NP	O
service	service	NN	I-NP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.375	0.375	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Carafate	Carafate	VB	B-VP	O
one	one	CD	B-NP	O
gram	gram	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	B-protein
t.i.d.	t.i.d.	NN	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tolerating	tolerate	VBG	I-VP	O
it	it	PRP	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
solid	solid	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
will	will	MD	B-VP	O
dictate	dictate	VB	I-VP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
assessment	assessment	NN	B-NP	O
and	and	CC	I-NP	O
plan	plan	NN	I-NP	O
by	by	IN	B-PP	O
problem	problem	NN	B-NP	O
list	list	NN	I-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
I.	I.	LS	B-NP	O
SEVERE	SEVERE	NN	I-NP	O
PANCREATITIS	PANCREATITIS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
solid	solid	JJ	I-NP	O
diet	diet	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
almost	almost	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
then	then	RB	O	O
resumed	resume	VBN	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
watery	watery	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
versus	versus	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-NP	O
C.	C.	FW	I-NP	O
diff	diff	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
presumptively	presumptively	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
and	and	CC	O	O
Pancrease	Pancrease	NN	B-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
units	unit	NNS	I-NP	O
t.i.d.	t.i.d.	RB	B-NP	O
1/2	1/2	CD	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
persisted	persist	VBD	B-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
prompted	prompt	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
n.p.o.	n.p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
more	more	JJR	I-ADVP	O
and	and	CC	O	O
another	another	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
30	30	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
showed	show	VBD	B-VP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
with	with	IN	B-PP	O
increase	increase	NN	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
necrosis	necrosis	NN	I-NP	O
or	or	CC	I-NP	O
pseudocyst	pseudocyst	NN	I-NP	O
formation	formation	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Also	Also	RB	B-VP	O
noted	note	VBN	I-VP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
significant	significant	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
and	and	CC	I-NP	O
TPN	TPN	NN	I-NP	B-protein
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
25	25	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
this	this	DT	B-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-ADVP	O
longer	longer	RBR	I-ADVP	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
either	either	CC	O	O
subjectively	subjectively	RB	B-PP	O
or	or	CC	I-PP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
does	do	VBZ	B-VP	O
occasionally	occasionally	RB	I-VP	O
have	have	VB	I-VP	O
mild	mild	JJ	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
actually	actually	RB	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
cause	cause	NN	I-NP	O
.	.	.	O	O

II	II	CD	B-NP	O
.	.	.	O	O

DIARRHEA	DIARRHEA	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
extensively	extensively	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
presumptively	presumptively	RB	B-ADVP	O
with	with	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
stool	stool	NN	I-NP	O
studies	study	NNS	I-NP	O
including	include	VBG	B-PP	O
Shigella	Shigella	NNP	B-NP	O
,	,	,	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
,	,	,	I-NP	O
Campylobacter	Campylobacter	NNP	I-NP	O
,	,	,	I-NP	O
ova	ova	NN	I-NP	O
and	and	CC	I-NP	O
parasites	parasite	NNS	I-NP	O
,	,	,	O	O
Microsporidia	Microsporidia	NNP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
stool	stool	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
fecal	fecal	JJ	I-NP	O
fast	fast	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
repeatedly	repeatedly	RB	B-ADJP	O
guaiac	guaiac	NN	I-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
his	his	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

III	III	CD	B-NP	O
.	.	.	O	O

RESOLVED	RESOLVED	NNP	B-NP	O
HEME	HEME	NNP	I-NP	B-protein
POSITIVITY	POSITIVITY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
earlier	earlier	RBR	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
stay	stay	NN	I-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
stools	stool	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
heme	heme	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
changed	change	VBN	B-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
ranitidine	ranitidine	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
guaiac	guaiac	JJ	I-NP	O
negative	negative	JJ	I-NP	O
stools	stool	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
.	.	.	O	O

SMALL	SMALL	NN	B-NP	O
PERIANAL	PERIANAL	NN	I-NP	O
ULCER	ULCER	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
perianal	perianal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pressure	pressure	NN	B-NP	O
from	from	IN	B-PP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
multiple	multiple	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
going	go	VBG	I-VP	O
on	on	RP	B-PRT	O
for	for	IN	B-PP	O
days	day	NNS	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
resolve	resolve	VB	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	O	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
be	be	VB	B-VP	O
swabbed	swab	VBN	I-VP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
for	for	IN	B-PP	O
HSV	HSV	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	B-protein
:	:	:	O	I-protein
I.	I.	NNP	B-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
:	:	:	O	O
Due	Due	NNP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
life	life	NN	I-NP	O
long	long	JJ	I-NP	O
diabetic	diabetic	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
receiving	receive	VBG	I-VP	O
45	45	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
regular	regular	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
finger	finger	NN	B-NP	O
stick	stick	NN	I-NP	O
q6h	q6h	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
stable	stable	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
his	his	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
and	and	CC	O	O
starts	start	VBZ	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
again	again	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
switched	switch	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
checks	check	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
before	before	IN	B-SBAR	O
his	his	PRP$	B-NP	O
meals	meal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
clinic	clinic	NN	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
below	below	IN	B-PP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
mild	mild	JJ	B-NP	O
bi-basilar	bi-basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
limited	limit	VBN	I-VP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
way	way	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
extra	extra	JJ	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
I	I	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
s	s	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
more	more	JJR	I-NP	O
crackles	crackle	NNS	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
having	have	VBG	B-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
relatively	relatively	RB	B-ADVP	O
well	well	RB	I-ADVP	O
here	here	RB	I-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
current	current	JJ	I-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
includes	include	VBZ	B-VP	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
Both	Both	DT	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
upwards	upward	NNS	B-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
allows	allow	VBZ	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
some	some	DT	B-NP	O
labile	labile	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
ranging	range	VBG	B-VP	O
anywhere	anywhere	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
systolics	systolic	NNS	I-NP	O
of	of	IN	B-PP	O
80s	80s	CD	B-NP	O
to	to	TO	B-PP	O
130s	130s	CD	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
and	and	CC	O	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
this	this	DT	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
0.375	0.375	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
taking	take	VBG	I-VP	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
and	and	CC	O	O
usually	usually	RB	B-VP	O
ranging	range	VBG	I-VP	O
from	from	IN	B-PP	O
95	95	CD	B-NP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
taking	take	VBG	I-VP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
some	some	DT	B-NP	O
extra	extra	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
per	per	IN	B-PP	O
your	your	PRP$	B-NP	O
directions	direction	NNS	I-NP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
20s	20s	CD	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
occasions	occasion	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
both	both	DT	B-NP	O
cases	case	NNS	I-NP	O
always	always	RB	B-ADVP	O
drifting	drift	VBG	B-VP	O
down	down	RB	B-ADVP	O
slowly	slowly	RB	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
delutional	delutional	JJ	B-NP	O
effects	effect	NNS	I-NP	O
plus	plus	CC	O	O
repeat	repeat	VB	B-VP	O
a	a	DT	B-NP	O
phlebotomy	phlebotomy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
transfused	transfuse	VBN	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
units	unit	NNS	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
is	be	VBZ	B-VP	O
hematocrit	hematocrit	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
days	day	NNS	I-NP	O
so	so	RB	B-ADVP	O
has	have	VBZ	B-VP	O
his	his	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
.	.	.	O	O

Also	Also	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
heme	heme	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
from	from	IN	B-PP	O
below	below	IN	B-PP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
says	say	VBZ	B-VP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

RHABDOMYOLYSIS	RHABDOMYOLYSIS	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CKs	CK	NNS	I-NP	B-protein
having	have	VBG	B-VP	O
normalized	normalize	VBN	I-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

INFECTIOUS	INFECTIOUS	JJ	B-NP	O
DISEASE	DISEASE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
here	here	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
presumptively	presumptively	RB	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
actually	actually	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
stool	stool	NN	I-NP	O
examinations	examination	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
fecal	fecal	JJ	I-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
temperature	temperature	NN	I-NP	O
curve	curve	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
pancreatitis	pancreatitis	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
a	a	DT	B-NP	O
phlegmon	phlegmon	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

SEVERE	SEVERE	NN	B-NP	O
PANCREATITIS	PANCREATITIS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
triple	triple	JJ	I-NP	O
lumen	lumen	NN	I-NP	O
catheter	catheter	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
our	our	PRP$	B-NP	O
feeling	feeling	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
your	your	PRP$	B-NP	O
directions	direction	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
slowly	slowly	RB	I-VP	O
advanced	advance	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
diet	diet	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
feel	feel	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
deserves	deserve	VBZ	B-VP	O
another	another	DT	B-NP	O
trial	trial	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
before	before	IN	B-SBAR	O
any	any	DT	B-NP	O
long	long	JJ	I-NP	O
term	term	NN	I-NP	O
decisions	decision	NNS	I-NP	O
is	be	VBZ	B-VP	O
made	make	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
his	his	PRP$	B-NP	O
nutrition	nutrition	NN	I-NP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
J-tube	J-tube	NNP	I-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
feeding	feeding	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
amylase	amylase	NN	I-NP	B-protein
and	and	CC	I-NP	O
lipase	lipase	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
are	be	VBP	B-VP	O
47	47	CD	B-NP	O
for	for	IN	B-PP	O
amylase	amylase	NN	B-NP	B-protein
and	and	CC	O	O
166	166	CD	B-NP	O
for	for	IN	B-PP	O
lipase	lipase	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
values	value	NNS	I-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
low	low	JJ	B-ADJP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
burnt	burnt	JJ	I-NP	O
out	out	RP	I-NP	O
pancreas	pancreas	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
GI	GI	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
agrees	agree	VBZ	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
assessment	assessment	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
start	start	VB	I-VP	O
taking	take	VBG	I-VP	O
p.o.	p.o.	FW	B-NP	O
again	again	RB	B-ADVP	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
pancreas	pancreas	NN	B-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
8	8	CD	I-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
t.i.d.	t.i.d.	RB	B-NP	O
half	half	JJ	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
exocrine	exocrine	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
clinically	clinically	RB	B-VP	O
very	very	RB	I-VP	O
closely	closely	RB	I-VP	O
including	include	VBG	I-VP	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
curve	curve	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
or	or	CC	I-NP	O
phlegmon	phlegmon	NN	I-NP	O
or	or	CC	I-NP	O
pseudocyst	pseudocyst	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
TPN	TPN	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
below	below	IN	B-PP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NNP	B-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
both	both	DT	B-PP	O
through	through	IN	I-PP	O
is	be	VBZ	O	O
TPN	TPN	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
switched	switch	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
per	per	IN	B-PP	O
endocrine	endocrine	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
that	that	WDT	B-NP	O
NPH	NPH	VBP	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Redist	Redist	NNP	B-NP	O
Nalereamer	Nalereamer	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
today	today	NN	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
occasionally	occasionally	RB	B-VP	O
continues	continue	VBZ	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mild	mild	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
120/70	120/70	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
is	be	VBZ	B-VP	O
69	69	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
69.0	69.0	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
of	of	IN	B-PP	O
1/4	1/4	CD	B-NP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
are	be	VBP	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
8.8	8.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
is	be	VBZ	B-VP	O
36	36	CD	B-NP	O
,	,	,	O	O
ADDplatelets	ADDplatelet	NNPS	B-NP	B-cell_type
of	of	IN	B-PP	O
348	348	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
SMA-7	SMA-7	NN	I-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.6	0.6	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
amylase	amylase	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
47	47	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
lipase	lipase	NN	I-NP	O
is	be	VBZ	B-VP	O
160	160	CD	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
Lakesfic	Lakesfic	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Littmann	Littmann	NNP	I-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sanislo	Sanislo	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
Longa	Longa	NNP	B-NP	O
Ent	Ent	NNP	I-NP	O
No	No	NNP	I-NP	O
on	on	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhalers	inhaler	VBZ	B-VP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	B-protein
q.i.d.	q.i.d.	RB	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.375	0.375	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
through	through	IN	B-PP	O
IVs	IV	NNS	B-NP	B-protein
while	while	IN	B-SBAR	O
being	be	VBG	B-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
TPN	TPN	NN	I-NP	O
orders	order	NNS	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
83.3	83.3	CD	B-NP	O
ml	ml	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
constantly	constantly	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
central	central	JJ	I-NP	O
solution	solution	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
aminoacid	aminoacid	NN	I-NP	O
,	,	,	O	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
Dextrose	Dextrose	NN	I-NP	O
,	,	,	O	O
400	400	CD	B-NP	O
lipids	lipid	NNS	I-NP	O
K-calories	K-calory	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
aminoacid	aminoacid	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
Novamine	Novamine	NN	I-NP	O
solution	solution	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
acetate	acetate	NN	I-NP	O
is	be	VBZ	B-VP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
His	His	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
30	30	CD	B-NP	O
mEq	mEq	NN	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
10	10	CD	B-NP	O
mEq	mEq	NN	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
50	50	CD	I-NP	O
mEq	mEq	NN	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
,	,	,	O	O
phosphate	phosphate	NN	B-NP	O
10	10	CD	I-NP	O
millimoles	millimole	NNS	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
.	.	.	O	O

Trace	Trace	NN	B-NP	O
elements	element	NNS	I-NP	O
1	1	CD	B-NP	O
millimoles	millimole	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
Mondays	Monday	NNS	I-NP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
10	10	CD	I-NP	O
ml	ml	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
94	94	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TPN	TPN	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
45	45	CD	B-NP	O
units	unit	NNS	I-NP	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
of	of	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
ranitidine	ranitidine	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
of	of	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Thiamine	Thiamine	NN	B-NP	O
every	every	DT	O	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
and	and	CC	O	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
800	800	CD	B-NP	O
mcg	mcg	NN	I-NP	O
of	of	IN	B-PP	O
folate	folate	NN	B-NP	O
every	every	DT	O	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
100	100	CD	B-NP	O
mcg	mcg	NN	I-NP	O
of	of	IN	B-PP	O
B-12	B-12	NN	B-NP	B-protein
q.	q.	NN	I-NP	O
Thursday	Thursday	NNP	B-NP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
DURING	DURING	VBG	B-VP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Exploratory	Exploratory	JJ	B-NP	O
laparotomy	laparotomy	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
AUSTIN	AUSTIN	NNP	B-NP	O
AMENDOLA	AMENDOLA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OY69	OY69	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FRITZ	FRITZ	NNP	B-NP	O
E.	E.	NNP	I-NP	O
BROMBERG	BROMBERG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AV40	AV40	NNP	I-NP	O
NO868/0457	NO868/0457	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
1015	1015	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

DWIAY04BK7	DWIAY04BK7	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/30/98	10/30/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/30/98	10/30/98	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

BASSASH	BASSASH	NN	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
AND	AND	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O

